Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorCOTTIN, Y.
dc.contributor.authorBLIN, Patrick
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBENICHOU, Jacques
dc.contributor.authorDUREAU-POURNIN, C.
dc.contributor.authorABOUELFATH, A.
dc.contributor.authorLASSALLE, R.
dc.contributor.authorDROZ-PERROTEAU, C.
dc.contributor.authorMISMETTI, P.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOORE, Nicholas
dc.date.accessioned2020-11-02T11:16:22Z
dc.date.available2020-11-02T11:16:22Z
dc.date.issued2018-08
dc.identifier.issn0195-668Xen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/11575
dc.language.isoENen_US
dc.subject.enPharmacoEpi-Drugs
dc.subject.enCIC1401
dc.title.enBenefit-risk profile of dabigatran compared with vitamin-K antagonists in elderly patients with non-valvular atrial fibrillation: results from a cohort study in the French nationwide claims database
dc.title.alternativeEuropean Heart Journalen_US
dc.typeArticle de revueen_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
bordeaux.journalEuropean Heart Journalen_US
bordeaux.page822-822en_US
bordeaux.volume39en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-02986452
hal.version1
hal.date.transferred2020-11-03T01:05:16Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European%20Heart%20Journal&rft.date=2018-08&rft.volume=39&rft.spage=822-822&rft.epage=822-822&rft.eissn=0195-668X&rft.issn=0195-668X&rft.au=COTTIN,%20Y.&BLIN,%20Patrick&BENICHOU,%20Jacques&DUREAU-POURNIN,%20C.&ABOUELFATH,%20A.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée